Integra Lifesciences Holdings

IART · NASDAQ

$13.33−$0.12 (−0.89%)TodayMarket closed ·
Prev close $13.45

Latest news

  • Press releaseGlobe Newswire

    Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

  • Press releaseBusiness Wire

    INTEGRA LIFESCIENCES HOLDINGS CORPORATION IART INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 21.2% Share Drop

  • Press releaseGlobe Newswire

    INTEGRA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corporation on Behalf of Integra Stockholders and Encourages Investors to Contact the Firm

  • Press releaseGlobe Newswire

    Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

  • Press releaseGlobe Newswire

    INTEGRA LIFESCIENCES HOLDINGS CORPORATION INVESTIGATION: IART Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

  • Press releasePRNewswire

    Nasdaq Hits Fresh Highs While Dow Slips and Small Caps Struggle for Direction

  • NewsVandana Singh

    Flood Damage Prompts Integra LifeSciences To Revise 2026 Outlook

  • Press releaseGlobe Newswire

    Integra LifeSciences (NASDAQ: IART) Investor Alert: Johnson Fistel Investigates Following Flooding-Related Outlook Cuts and 21% Stock Decline

  • Press releasePRNewswire

    Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week

  • Press releasePRNewswire

    Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)

  • NewsAvi Kapoor

    Crude Oil Down Over 1%; US Factory Orders Edge Higher In August

  • Press releaseGlobe Newswire

    Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

  • Press releaseGlobe Newswire

    Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

  • Press releaseGlobe Newswire

    Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

  • Press releaseGlobe Newswire

    Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

  • Press releaseGlobe Newswire

    Integra LifeSciences to Present at the 2026 Wells Fargo Healthcare Conference and the 2026 Morgan Stanley Healthcare Conference

  • Press releaseGlobe Newswire

    Integra LifeSciences Reports Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm

  • Press releaseGlobe Newswire

    Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026

  • Press releasePRNewswire

    One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu's Move Into Medical Aesthetics

  • Press releaseGlobe Newswire

    Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

  • Press releaseGlobe Newswire

    Integra LifeSciences Announces Key Executive Appointments

  • Press releaseGlobe Newswire

    Regenerative Medicine's Next Chapter: Inside the Race to Make the Body Rebuild Itself

  • Press releaseGlobe Newswire

    The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

  • Press releaseGlobe Newswire

    Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

  • Press releaseGlobe Newswire

    A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

  • Press releasePRNewswire

    The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts

  • Press releaseGlobe Newswire

    Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

  • Press releasePRNewswire

    Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

  • Press releaseGlobe Newswire

    Integra LifeSciences Reports First Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Falls Over 2%; ISM Services PMI Rises In April

  • NewsAvi Kapoor

    Integra LifeSciences Posts Upbeat Results, Joins Air Transport Services, Freshpet, Yum China And Other Big Stocks Moving Higher On Monday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.